English Українська
  • Main
  • Useful links
  • Information for Contributors
  • About
  • Editorial board

  • Article
    Gerush І. V., Cherniukh О. G., Dikal М. V.

    PECULIARITIES OF TRANSFERASE ENZYMATIC ACTIVITY CHANGES IN SIMULATING ALLOXAN-INDUCED DIABETES MELLITUS IN RATS


    About the author: Gerush І. V., Cherniukh О. G., Dikal М. V.
    Heading EXPERIMENTAL MEDICINE
    Type of article Scentific article
    Annotation A subject of study in this work is exploration of main biochemical indices of the blood plasma of albino rats with the background of induced diabetes mellitus (DM). Alloxan DM was modeled in rats by intraperitoneal injection of a 5% liquid of alloxan monohydrate in the dose of 150 mg/kg of body weight. On the 14th day of the experiment, the changes in the indices were compared with the control data . The results of our studies have found a pronounced hyperglycemia ranging within 11-20 mmol/L. An average glucose concentration was 12,6 ± 1,28 mmol/L that was twice as much as compared to the similar index in the group of control animals 6,0 ± 0,13 mmol/L. A significant increase in AST and GGT activity was observed, respectively, by 84% (p <0.01) and 79% (p<0.01), while the increase in ALT activity was slightly less – by 36% (p<0.05). It has been established that against a background of significant hyperglycemia (12.6 ± 1.28 mmol/L), the change in enzyme activity is a more sensitive indicator of the acute phase of alloxan DM development than such generally accepted indicators as the concentration of total protein, albumin, urea, creatinine. Furthermore, the enzyme activity ratios may indicate necrotic disorders of the functional state of the liver, as the primary organ responsible for rearranging the metabolic pathways due to the lysis of the insulin-producing cells.
    Tags alloxan's diabetes mellitus, blood plasma, biochemical indices, albino rats
    Bibliography
    • Baryisheva E. V. Izmenenie pokazateley prooksidantno-antioksidantnoy sistemyi pri snizhenii kontsentratsii deyteriya v organizme laboratornyih zhivotnyih s alloksanovyim diabetom. / E. V. Baryisheva // Fundamentalnyie issledovaniya. – 2015. – No.1. – C. 457-461.
    • Mozheyko L. A. Eksperimentalnyie modeli dlya izucheniya saharnogo diabeta. Chast I. Alloksanovyiy diabet. / L. A. Mozheyko // Zhurn. Grodnen. gos. med. un-t. – 2013. – No. 3, T.43. – S. 26-29.
    • Palchikova N. A. Gormonalno-biohimicheskie osobennosti alloksanovoy i streptozototsinovoy modeley eksperimentalnogo diabeta. / N. A. Palchikova, N. V. Kuznetsova, O. I. Kuzminova [i dr.] // Byul. SO RAMN. – 2013 – No.6. – S. 18-24.
    • Telushkin P. K. Osobennosti azotistogo obmena i energoobespecheniya miokarda pri insulinovoy gipoglikemii u kryis. [Elektronniy resurs]: / P. K. Telushkin, A. Yu. Stelmah, N. B. Medvedeva [i dr.] // Sovremennyie problemyi nauki i obrazovaniya. –2014. – No. 5. Rezhim dostupa: https://www.science-education.ru/ru/article/view?id=15112
    • Tkachenko V. I. Analiz poshyrenosti ta zakhvoriuvanosti na tsukrovyi diabet sered naselennia svitu ta Ukrainy za 2003–2013 rr. / V. I. Tkachenko // Liky Ukrainy plius. – 2014. – No.4 (21). – S. 55-59.
    • Gati Mohannad Abdulrazzak Gati. Fizizologo-biohimicheskie aspektyi adaptatsii kryis k usloviyam alloksanovogo diabeta / Gati Mohannad Abdulrazzak Gati, D. N. Fedorin, N. D. Polyakova-Semenova [et al.] // Fundamentalnyie issledovaniya. – 2013. – No.11(3). – С. 465-469.
    • Bukhari Syed Shahid Imran. Dose optimization of Alloxan for diabetes in albino mice / Bukhari Syed Shahid Imran, Abbasi Muddasir Hassan, Khan Muhammad Khalil Ahmad // Biologia (Pakistan). – 2015. – 61(2). – P. 301-305.
    • Chatzigeorgiou A. The Use of Animal Models in the Study of Diabetes Mellitus / А. Chatzigeorgiou, А. Halapas, К. Kalafatakis [et al.] // Internat. J. of Exper. and Clinic. Pathophys. And Drug Research. – 2009. – No.2. – Vol.23. – Р. 245-258.
    • Lucchesi A. N. Diabetes mellitus triggers oxidative stress in the liver of alloxan treated rats: a mechanism for diabetic chronic liver disease / A. N. Lucchesi, N. Tavares de Freitas, L. L Cassettari [et al.] // Acta Cir. Bras. – 2013 – 28(7), P. 502-508. DOI: 10.1590/S0102-86502013000700005
    • Mnafgui K. Inhibition of key enzymes related to diabetes and hypertension by Eugenol in vitro and in alloxan-induced diabetic rats. / K. Mnafgui, F. Kaanich, A. Derbali [et al.] // Archives of Physiology and Biochemistry. – 2013. – 119(5). – Р.225-233.
    • Mohd Azam Hyder. Comparative Levels of ALT, AST, ALP and GGT in Liver associated Diseases. / Mohd Azam Hyder, Marghoob Hasan, Abdelmarouf Hassan Mohieldein // European Journal of Experimental Biology. – 2013. – No.3 (2). – P. 280-284.
    • Radenkoviсh М. Experimental diabetes induced by alloxan and streptozotocin: The current state of the art / М. Radenkoviсh, М Stojanoviсh, М. Prostran // J. of Pharm. and Toxicol. Methods. – 2016. – No.78. – Р.13-31.
    Publication of the article «World of Medicine and Biology» №4(62), 2017 year, 123-126 pages, index UDK 616.153: 616.379-008.64]-092.9
    DOI 10.26724/2079-8334-2017-4-62-123-126